{"id":"W4295818074","doi":"10.1016/j.annonc.2022.07.665","title":"537P A phase I/II study of oral chk1 inhibitor LY2880070 in combination with low-dose gemcitabine in patients with advanced or metastatic ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ozmosis Research (Canada); Alberta Health Services; Princess Margaret Cancer Centre; McGill University Health Centre; University Health Network; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Oncology; Internal medicine; Phases of clinical research; Ovarian cancer; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007151892,0.001186702,0.002382364,0.0005241915,0.0003718304,0.001065327,0.0007951224,0.001038455,0.006007578],"category_scores_gemma":[0.0005245103,0.0006203842,0.001545419,0.0005210782,0.0008542626,0.0007034899,0.0003476032,0.00357058,0.001173972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000956504,"about_ca_system_score_gemma":0.001908422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002436553,"about_ca_topic_score_gemma":0.007826753,"domain_scores_codex":[0.9997675,0.00008726182,0.00001107644,0.00004424787,0.00001987333,0.00007001073],"domain_scores_gemma":[0.9996994,0.0000449959,0.0000391812,0.00002425308,0.00001697348,0.0001752948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7275381,0.0459162,0.004564381,0.001370997,0.002276329,0.0003712172,0.0002324696,0.003767261,0.06698228,0.0005152288,0.008674986,0.1377906],"study_design_scores_gemma":[0.6346281,0.3421072,0.01064321,0.00006774141,0.001133281,0.0002580094,0.00009250142,0.001554041,0.005031642,0.0002285686,0.004207299,0.0000484617],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884982,0.003157913,0.0005536023,0.0009895553,0.0002289119,0.001584089,0.001631748,0.0002111601,0.00314483],"genre_scores_gemma":[0.9840786,0.004173871,0.001249876,0.0009077049,0.0001700231,0.001521498,0.003542343,0.00007043657,0.004285749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006007578,"threshold_uncertainty_score":0.02009737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05685263538688413,"score_gpt":0.4240513685658881,"score_spread":0.367198733179004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}